等待开盘 06-24 09:30:00 美东时间
+4.160
+1.64%
Citrini Research has updated its healthcare basket as the firm grows increasingly bullish on a recovery in life sciences, bioprocessing, and healthcare infrastructure stocks driven by both cyclical im...
06-09 23:41
New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatmentBURLINGTON, N.C., May 28, 2026 /PRNewswire/ -- Labcorp
05-28 19:14
MyLabcorp connects lab results, educational content and AI-enabled features in a secure, personalized mobile experienceLeverages OpenAI models designed to help users understand their results, ask questions and identify
05-20 19:11
Labcorp's full test menu will be available through Epic's Aura platformIntegration builds on the successful deployment of Invitae genetic testing and accelerates access to the latest genetic and specialty diagnostics
05-12 19:23
华盛资讯5月5日讯,实验美控公布2026财年Q1业绩,公司Q1营收35.38亿美元,同比增长5.8%,归母净利润2.78亿美元,同比增长30.5%。
05-05 02:32
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Labcorp 2026年第一季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **整体企业表现:** - 企业总收入达到35亿美元,同比增长5.8% - 调整后营业利润率扩大至14.4%,较上年同期提升超过30个基点 - 调整后每股收益为4.25美元,同比增长10.6% - 自由现金流为7,100万美元,而上年同期为现金流出1.08亿美元 **分部门表现:** - 诊断实验室收入28亿美元,同比增长5% - 生物制药实验室服务(BLS)收入7.81亿美元,同比增长8.2% - 诊断部门调整后营业利润率为16.6%,较上年同期16.
05-01 12:03
Labcorp shares rise after Q1 earnings beat and higher guidance, supported by diagnostics growth and investments in AI and robotics.
05-01 00:05
华盛资讯4月30日讯,实验美控公布2026财年Q1业绩,公司Q1营收35.38亿美元,同比增长5.8%,归母净利润2.78亿美元,同比增长30.5%。
04-30 21:47
Companies Reporting Before The Bell • Sonic Automotive (NYSE:SAH) is projected ...
04-30 19:11